Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 7
Submit an article Journal homepage
1,336
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients

Steve BoudewijnsDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Kalijn F. BolDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Gerty SchreibeltDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Harm WestdorpDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Johannes C. TextorDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Michelle M. van RossumDepartment of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands
,
Nicole M. ScharenborgDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Annemiek J. de BoerDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Mandy W. M. M. van de RaktDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Jeanne M. PotsDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Tom G. M. van OorschotDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Tjitske Duiveman-de BoerDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Michel A. Olde NordkampDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
,
Wilmy S. E. C. van MeeterenDepartment of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands
,
Winette T. A. van der GraafDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands;The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom
,
Johannes J. BonenkampDepartment of Surgical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
,
Johannes H. W. de WiltDepartment of Surgical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
,
Erik H. J. G. AarntzenDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands;Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
,
Cornelis J. A. PuntDepartment of Medical Oncology, Academic Medical Center, Amsterdam, the Netherlands
,
Winald R. GerritsenDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands
,
Carl G. FigdorDepartment of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands
&
I. Jolanda M. de VriesDepartment of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands;Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the NetherlandsCorrespondence[email protected]
 show all
Article: e1191732 | Received 11 Apr 2016, Accepted 15 May 2016, Published online: 11 Jul 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Martine Bloemendal, Kalijn F. Bol, Steve Boudewijns, Mark A.J. Gorris, Johannes H.W. de Wilt, Sandra A.J. Croockewit, Michelle M. van Rossum, Anna L. de Goede, Katja Petry, Rutger H.T. Koornstra, Carl Figdor, Winald R. Gerritsen, Gerty Schreibelt & I. Jolanda M. de Vries. (2022) Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients. OncoImmunology 11:1.
Read now
Lorenzo Pilla, Soldano Ferrone & Cristina Maccalli. (2018) Methods for improving the immunogenicity and efficacy of cancer vaccines. Expert Opinion on Biological Therapy 18:7, pages 765-784.
Read now
Abhishek D. Garg, Sanket More, Nicole Rufo, Odeta Mece, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. OncoImmunology 6:12.
Read now
Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Lionel Apetoh. (2017) Trial Watch: Adoptively transferred cells for anticancer immunotherapy. OncoImmunology 6:11.
Read now
Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Dendritic cell-based anticancer immunotherapy. OncoImmunology 6:7.
Read now

Articles from other publishers (9)

Yunchao Zhang, Chenxin Liu, Chunjie Wu & Linjiang Song. (2023) Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives. Biomedicine & Pharmacotherapy 159, pages 114257.
Crossref
Filippo Galli, Jesus Vera Aguilera, Belinda Palermo, Svetomir N. Markovic, Paola Nisticò & Alberto Signore. (2020) Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Liuxue Sheng, Xiang Chen, Qh Wang, Sali Lyu & Pengping Li. (2020) Interferon-α2b enhances survival and modulates transcriptional profiles and the immune response in melanoma patients treated with dendritic cell vaccines. Biomedicine & Pharmacotherapy 125, pages 109966.
Crossref
Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn F. Bol, Gerty Schreibelt, Erik H. J. G. Aarntzen, W. Joost Lesterhuis, Mark A. J. Gorris, Alexandra Croockewit, Lieke L. van der Woude, Michelle M. van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V. Hato, Winette T. A. van der Graaf, Cornelis J. A. Punt, Rutger H. T. Koornstra, Winald R. Gerritsen, Carl G. Figdor & I. Jolanda M. de Vries. (2020) Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial. Cancer Immunology, Immunotherapy 69:3, pages 477-488.
Crossref
Alessandro A. E. Testori, Simone Ribero, Alice Indini & Mario Mandalà. (2019) Adjuvant Treatment of Melanoma: Recent Developments and Future Perspectives. American Journal of Clinical Dermatology 20:6, pages 817-827.
Crossref
Cristina Maccalli. 2019. Cancer Stem Cell Resistance to Targeted Therapy. Cancer Stem Cell Resistance to Targeted Therapy 137 151 .
Tonke K. Raaijmakers & Marleen Ansems. (2018) Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands. Cancer Immunology, Immunotherapy 67:11, pages 1789-1796.
Crossref
Larisa J. Geskin, James J. Damiano, Christina C. Patrone, Lisa H. Butterfield, John M. Kirkwood & Louis D. Falo. (2018) Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma. Melanoma Research 28:3, pages 211-221.
Crossref
Svenja F. B. Mennens, Matteo Bolomini-Vittori, Jorieke Weiden, Ben Joosten, Alessandra Cambi & Koen van den Dries. (2017) Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells. Scientific Reports 7:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.